Its not every day that the Food and Drug Administration approves a drug three months ahead of schedule Or approves a pill that could take the place of injections Or gives the OK to a medicine named for the CEO who started a company to   But all those things just happened United Therapeutics Orenitram got the   as a treatment for   The lifethreatening illness is caused by constriction of the arteries that carry blood from the heart to the lungs Its marked by fatigue shortness of breath chest pain and heart failure Drugs that relax the arteries can help But a core treatment used to be available only by injection When I started the company  years ago the only option for treating pulmonary hypertension was intravenous   Martine Rothblatt CEO of United Therapeutics told investors in a celebratory conference call Monday My young daughter looked at me and said Cant there be a pill  Now there is Orenitram The name comes from Martine Ro as in Martine Rothblatt backward What it has resulted in is something that as the parent of a lovely young lady with pulmonary hypertension I cannot even put into words the emotional meaning that it has to have a pill form of prostacyclin Rothblatt said A little later in the call she tried When something takes a long time to bake be it a turkey or a cake the bad thing is that youre hungry and youre starving for a long time Rothblatt said But the good thing is you usually have an awesome meal at the end Its a very very similar situation with Orenitram This baby has taken a long time to bake  no doubt about it There are many drugs available for pulmonary hypertension including pills containing the same active ingredients as Viagra and Cialis But Orenitram marks a first in the US  a prostacyclin that can be taken by mouth the company said Orenitram wont be available for sale for about six months the company said and its exact price hasnt been determined either But it will be very expensive about  a year according to an estimate by Dr Mark Schoenebaum an   Insurers generally pay for pulmonary hypertension drugs though there were questions from analysts about whether health plans would pay for Orenitram if its used in combination with other drugs The FDA approved Orenitram on the basis of a study that gauged its safety and effectiveness as a standalone treatment The drug helped people walk a little farther in a timed walking test The most common side effects seen in the study were headache nausea and diarrhea Rothblatt acknowledged that the cost of the drugs is high but manageable because pulmonary hypertension   though the exact prevalence is hard to pin down Theres far more to the Orenitram story Martine Rothblatt used to be Martin a founder of Sirius Satellite Radio before undergoing gender reassignment surgery and becoming a drug company executive For more on Rothblatt and United Therapeutics read the    by   Matthew Herper Finally you check out Rothblatt honoring daughter Jenesis at the th anniversary of the founding of the company in the video below